Results 31 to 40 of about 63,852 (318)

Glucocorticoids Inhibit Sodium Depletion-induced Salt Appetite in Rat [PDF]

, 2010
Glucocorticoids, produced in adrenal cortex, exert potent natriuretic and diuretic actions in the kidney. Recently, it has been found that glucocorticoids could upregulate the expression of natriuretic peptide receptor A (NPR-A), the primary receptor of ...
Chao Liu, Jing Guan, Kunshen Liu, Ying Chen   +3 more
core   +2 more sources

Plasma natriuretic peptides in children and adolescents with obstructive sleep apnoea and their changes following intervention

Frontiers in Pediatrics, 2014
Objective: This study aimed to evaluate circulating natriuretic peptides (NP) concentration in obese and non-obese children and adolescents with and without OSA, and their levels following OSA treatment.Methods: Subjects with habitual snoring and ...
Albert Martin Li, Chun T eAu, Jodie eZhu, Kate eChan, Michael eChan, Dennis eLee, Yun K eWing   +6 more
doaj   +1 more source

Different behaviour of the N-terminal and C-terminal fragment of proatrial natriuretic factor in plasma of healthy subjects as well as of patients with cirrhosis [PDF]

, 1990
N-terminal (atrial natriuretic factor (ANF) 1-98) and C-terminal (ANF 99-126) fragments of proatrial natriuretic factor (NTA and CTA, respectively) were determined in plasma of healthy subjects adopting different postures and in patients with cirrhosis ...
Arendt, Rainer M., Cantin, M., Gerbes, Alexander L., Paumgartner, Gustav, Thibault, G., Vollmar, Angelika M.   +5 more
core   +1 more source

Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

Arthritis &Rheumatology, EarlyView.
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean, Carrie Richardson, Anthony J. Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial

European Journal of General Practice
Background Atrial fibrillation (AF) is a common treatable risk factor for stroke. Screening for paroxysmal AF in general practice is difficult, but biomarkers might help improve screening strategies.Objectives We investigated six blood biomarkers for ...
Katharina Schmalstieg-Bahr, David J. Gladstone, Eva Hummers, Johanna Suerbaum, Jeff S. Healey, Antonia Zapf, Denise Köster, Stefanie M. Werhahn, Rolf Wachter   +8 more
doaj   +1 more source

Atrial Natriuretic Peptide, a Regulator of Nuclear Factor-κB Activation in Vivo [PDF]

, 2007
Natriuretic peptides (NPs) comprise a family of vasoactive hormones that play important roles in the regulation of cardiovascular and renal homeostasis.
Keller, Melanie, Kiemer, Alexandra K., Koch, Elke, Ladetzki-Baehs, Kathrin, Vollmar, Angelika M., Wendel, Albrecht, Zahler, Stefan   +6 more
core   +1 more source

Variability in ACT Response to Standard UFH Bolus During PCI: A Prospective Study on Determinants of Subtherapeutic Anticoagulation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu, Antonin Trimaille, Amandine Granier, Adrien Carmona, Anis Elidrissi, Marion Kibler, Laurence Jesel, Patrick Ohlmann, Laurent Sattler, Olivier Morel   +9 more
wiley   +1 more source

Signs of left atrial disease and 10-year risk of atrial fibrillation.

PLoS ONE, 2022
BackgroundThe contribution of left atrial disease and excessive supraventricular ectopic activity (ESVEA) to the risk for incident atrial fibrillation (AF) is incompletely understood.ObjectiveTo analyse the ten-year risk to develop AF in patients with ...
Tobias Uhe, Tina Stegmann, Romy Langhammer, Nikolaos Dagres, Ulrich Laufs, Rolf Wachter   +5 more
doaj   +1 more source

Successful Revascularization of Chronic Total Occlusions in Patients With Chronic Thromboembolic Pulmonary Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Chronic thromboembolic pulmonary disease (CTEPD) leads to chronic total occlusions (CTOs) of the pulmonary arteries in a minority of patients. Treatment of CTOs with balloon pulmonary angioplasty (BPA) may substantially improve patient hemodynamics but presents unique technical challenges and has previously been associated with a ...
Elliot J. Stein, Peter J. Leary, Lauren N. Carlozzi, Samuel G. Rayner, Zachary L. Steinberg   +4 more
wiley   +1 more source

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background We tested associations of cardiac biomarkers of myocardial stretch, injury, inflammation, and fibrosis with the risk of incident atrial fibrillation (AF) in a prospective study of chronic kidney disease patients.
Julio A. Lamprea‐Montealegre, Leila R. Zelnick, Michael G. Shlipak, James S. Floyd, Amanda H. Anderson, Jiang He, Rob Christenson, Stephen L. Seliger, Elsayed Z. Soliman, Rajat Deo, Bonnie Ky, Harold I. Feldman, John W. Kusek, Christopher R. deFilippi, Myles S. Wolf, Tariq Shafi, Alan S. Go, Nisha Bansal   +17 more
doaj   +1 more source